Form 4: Illumina Director Anna Richo Receives Restricted Stock Unit Grant

Illumina, Inc. Director Anna Richo was granted 3,780 restricted stock units (RSUs) on May 21, 2025, as part of her compensation, increasing her beneficial ownership to 6,455 units.

Summary

• Illumina, Inc. Director Anna Richo acquired 3,780 shares of Common Stock in the form of restricted stock units (RSUs) on May 21, 2025.
• The RSUs were granted at a price of $0, indicating they are part of a compensation package.
• Following this transaction, Ms. Richo's beneficial ownership of Illumina common stock increased to 6,455 units.
• The granted RSUs are subject to vesting, with 100% vesting on the earlier of the one-year anniversary of the grant date or the date immediately preceding the company's annual stockholders' meeting for the year following the grant, provided Ms. Richo continues to serve as a director.
• An adjustment occurred in connection with Illumina's spin-out of Grail, Inc. on June 24, 2024, which resulted in Ms. Richo's unvested RSUs increasing by 53 units.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the RSU grant aligns the director's interests with shareholders, which is generally viewed favorably for corporate governance and long-term value creation. It's a routine compensation event, not indicative of major operational changes.

Positives

• The grant of restricted stock units to Director Anna Richo aligns her interests with those of the shareholders, as her compensation is tied to the company's future performance and stock value.
• The increase in beneficial ownership demonstrates continued commitment from a key board member.

Future Outlook

The restricted stock units are expected to vest on the earlier of the one-year anniversary of the grant date or the date immediately preceding the company's annual stockholders' meeting for the year following the grant, contingent on the director's continued service.

Industry Context

Equity compensation, such as restricted stock units, is a common practice across industries, including the biotechnology and genomics sectors, to incentivize and retain directors and executives by aligning their financial interests with the long-term performance of the company.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard form of non-cash compensation in publicly traded companies, consistent with corporate governance best practices aimed at aligning director incentives with shareholder value.
• Many companies, including peers in the life sciences and diagnostics industry, utilize similar equity-based compensation plans for their board members.

Corporate Governance

Related Party Transactions

• Grant of restricted stock units to Anna Richo, a director of Illumina, Inc., as part of her compensation package.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the company's stock performance, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 3,780 restricted stock units based on the specified conditions (one-year anniversary of grant or prior to next annual meeting, contingent on continued service).

Key Dates

Keywords

Illumina, ILMN, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, equity grant, corporate governance